Carotid angioplasty and stenting: evolution and current status
1University of Pittsburgh Medical Center, Division of Vascular Surgery, Pittsburgh, PA, USA.
Hospital Practice (1995)
|September 2, 2011
Summary
Carotid angioplasty and stenting is an evolving, safe alternative to carotid endarterectomy for carotid stenosis. Ongoing trials define optimal use cases for this interventional procedure.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Carotid endarterectomy (CEA) has long been the standard treatment for carotid stenosis.
- Carotid angioplasty and stenting (CAS) has emerged as a viable alternative.
- Optimal patient selection for CAS versus CEA is under investigation.
Purpose of the Study:
- To review the evolution of CAS.
- To examine the evidence supporting current CAS indications.
- To discuss limitations, preprocedural evaluations, and periprocedural management of CAS.
Main Methods:
- Review of existing clinical trials and evidence.
- Analysis of procedural outcomes and safety data.
- Synthesis of current guidelines and expert opinion.
Main Results:
- CAS is a feasible and relatively safe option for managing carotid stenosis.
- Clinical trials are ongoing to determine the ideal role of CAS compared to CEA.
- Understanding preprocedural assessment and periprocedural care is crucial for successful CAS.
Conclusions:
- CAS represents a significant advancement in carotid stenosis management.
- Further research is needed to refine indications and optimize CAS use.
- A comprehensive approach to evaluation and management enhances patient outcomes.
Related Concept Videos
01:26Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
01:26Angina IV: Management
219
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
219
01:27Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
01:27Coronary Artery Disease V: Interprofessional Care
205
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205